Objective-The aim was to assess the extent to which selection bias affects a casecontrol study of breast cancer screening in which attenders and non-attenders for screening are compared.
S M Moss, M E Summerley, B T Thomas, R Ellman, J 0 P Chamberlain
Abstract
Objective-The aim was to assess the extent to which selection bias affects a casecontrol study of breast cancer screening in which attenders and non-attenders for screening are compared.
Design-There were two retrospective case-control studies, one estimating the risk ofdeath from breast cancer in women in the screening district relative to those in the comparison district (study A), the second estimating the relative risk for women who had ever been screened compared with women who had never been screened in the screening district alone (study B). For cases and controls in study B, the women's screening history was summarised for the time period from date of entry to diagnosis ofthe case, or the equivalent time from date of entry for the matched controls. For cases detected by screening, the screen at which cancer was detected was included in the screening history.
Subjects-Cases were deaths from breast cancer in women with disease diagnosed after entry to the trial, up 10 For study B, a new set of age matched controls for the Guildford cases only was drawn, this time from the Guildford population alone.
The screening history for cases and controls was summarised as for study A, and a matched analysis carried out of the effect on breast cancer mortality of ever attending for screening compared with non-attenders.
A postal questionnaire was sent to control women in order to collect information on risk (0 38-090) for women who had never or had ever been screened compared with those in Stoke-onTrent not offered screening. The relative risk for the ever screened compared with the never screened in Guildford is 0 50 (95% confidence interval 0-27-0 92). Table IV gives the results of study B, the "internal" case-control study, within the Guildford population alone; 55% (28/51) of the cases and 71% (181/255) of the controls had attended for screening at least once. The matched analysis gives a relative risk of 0 51 (95% confidence interval 0 27-0-98) for women ever screened compared with those never screened, which is very similar to the estimate of 0 50 obtained from the similar analysis using different controls in study A. Stoke-on-Trent Guildford total attenders non-attenders never screened does not predict the likely effect of screening on a population unless full compliance can be expected. With no selection bias and a compliance of 7200, a relative risk of 0-51 in screened women would result in a 3500 (=0 72 x [1-0 51] x 100) overall mortality reduction in the population. In study A, however, the reduction for Guildford was found to be 2500, very similar to the results from the cohort analysis. It would therefore appear from the results of this study that a comparison of screened and never screened women within the population offered screening (study B) gives a biased estimate of the overall benefit of screening to the population. 
